Neue Entwicklungen in der StrahlentherapieNew developments in radiotherapy

[1] Lei C(2019)Long-term survival and late toxicity associated with pelvic intensity modulated radiation therapy (IMRT) for cervical cancer involving CT-based positive lymph nodes Front Oncol 81 424-430

[2] Ma S(2011)Helical tomotherapy versus conventional intensity-modulated radiation therapy for primary chemoradiation in cervical cancer patients: an intraindividual comparison Int J Radiat Oncol Biol Phys 51 261-266

[3] Huang M(2001)Intensity-modulated radiation therapy (IMRT) reduces small bowel, rectum, and bladder doses in patients with cervical cancer receiving pelvic and para-aortic irradiation Int J Radiat Oncol Biol Phys 114 395-401

[4] An J(2015)Comparison of VMAT and IMRT strategies for cervical cancer patients using automated planning Radiother Oncol 26 770-776

[5] Liang B(2016)Correlations between radiation dose in bone marrow and hematological toxicity in patients with cervical cancer: a comparison of 3DCRT, IMRT, and rapidARC Int J Gynecol Cancer 41 1082-1810

[6] Dai J(2015)Adjuvant intensity-modulated radiotherapy (IMRT) with concurrent paclitaxel and cisplatin in cervical cancer patients with high risk factors: A phase II trial Eur J Surg Oncol 20 794-800

[7] Wu L(2016)Toxicity and early clinical outcomes in cervical cancer following extended field helical tomotherapy to para-aortic lymph nodes Cancer Radiother 10 382-386

[8] Marnitz S(2019)Short term outcomes of helical tomotherapy during concurrent chemoradiotherapy for advanced cervical cancer Mol Clin Oncol 14 135-PMC5273793

[9] Lukarski D(2019)Incidental dose distribution to locoregional lymph nodes of breast cancer patients undergoing adjuvant radiotherapy with tomotherapy—is it time to adjust current contouring guidelines to the radiation technique? Radiat Oncol 12 31-121

[10] Kohler C(2017)Helical TomoTherapy for locally advanced or recurrent breast cancer Radiat Oncol 122 116-51

[1] Lei C(2019)Long-term survival and late toxicity associated with pelvic intensity modulated radiation therapy (IMRT) for cervical cancer involving CT-based positive lymph nodes Front Oncol 81 424-430

[2] Ma S(2011)Helical tomotherapy versus conventional intensity-modulated radiation therapy for primary chemoradiation in cervical cancer patients: an intraindividual comparison Int J Radiat Oncol Biol Phys 51 261-266

[3] Huang M(2001)Intensity-modulated radiation therapy (IMRT) reduces small bowel, rectum, and bladder doses in patients with cervical cancer receiving pelvic and para-aortic irradiation Int J Radiat Oncol Biol Phys 114 395-401

[4] An J(2015)Comparison of VMAT and IMRT strategies for cervical cancer patients using automated planning Radiother Oncol 26 770-776

[5] Liang B(2016)Correlations between radiation dose in bone marrow and hematological toxicity in patients with cervical cancer: a comparison of 3DCRT, IMRT, and rapidARC Int J Gynecol Cancer 41 1082-1810

[6] Dai J(2015)Adjuvant intensity-modulated radiotherapy (IMRT) with concurrent paclitaxel and cisplatin in cervical cancer patients with high risk factors: A phase II trial Eur J Surg Oncol 20 794-800

[7] Wu L(2016)Toxicity and early clinical outcomes in cervical cancer following extended field helical tomotherapy to para-aortic lymph nodes Cancer Radiother 10 382-386

[8] Marnitz S(2019)Short term outcomes of helical tomotherapy during concurrent chemoradiotherapy for advanced cervical cancer Mol Clin Oncol 14 135-PMC5273793

[9] Lukarski D(2019)Incidental dose distribution to locoregional lymph nodes of breast cancer patients undergoing adjuvant radiotherapy with tomotherapy—is it time to adjust current contouring guidelines to the radiation technique? Radiat Oncol 12 31-121

[10] Kohler C(2017)Helical TomoTherapy for locally advanced or recurrent breast cancer Radiat Oncol 122 116-51